Cases of Covid JN.1 sub-variant detected in India: Symptoms, precautions & other FAQs
Wednesday, 20 December 2023 The JN.1 variant of Covid, causing concern in India, has mild to moderate symptoms such as fever, runny nose, sore throat, headaches, loss of appetite, and extreme fatigue. Gastrointestinal problems may also occur. The central government has issued advisories to state governments, urging adequate health arrangements. The WHO classifies JN.1 as a "variant of interest" with limited threat. Vaccinations targeting the spike protein should remain effective against JN.1. To prevent infection, experts recommend masking up in crowded areas, staying in well-ventilated spaces, and frequent handwashing.
Following the identification of the initial case of the Coronavirus sub-variant JN.1 in Kerala, several states in the country have witnessed a rise in Covid cases. Insacog, the central government's consortium of laboratories, has detected 19 sequences of the JN.1 sub-variant, a descendant of BA.2.86...
A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccine’s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research.
#IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity
~HT.97~PR.152~
India reported 841 new COVID-19 cases in 24 hours, the highest in 227 days, with 4,309 active cases. Three deaths were recorded in Kerala, Karnataka, and Bihar. The surge follows a new variant and..
The JN.1 sub-variant is on the rise with 109 cases reported in India. Stay informed with the latest developments, insights, and precautions. Join us for an urgent update on the evolving Covid..
A new, fast-spreading COVID-19 variant named JN.1 now makes up 44% of all cases nationwide, more than doubling its share from the week before, according to data from the U.S. Centers for Disease..
As per the latest data from the US Centers for Disease Control and Prevention (US CDC), the JN.1 variant, the new subvariant of the Omicron variant of the... IndiaTimes
Haryana health department reviews Covid-19 cases in Kerala and the emergence of JN.1 sub-variant, a descendant of BA.2.86 lineage. No indication of increased... IndiaTimes
India records four more Covid-19 deaths in 1 day, bringing the total to Karnataka, Kerala, Bengal, and Delhi. The daily tally of infections is 702. The current... IndiaTimes